Yue Tian Selected Research

dibenzocyclooctadiene

12/2021

Protective effects of Schisandrin B against D-GalN-induced cell apoptosis in human hepatocyte (L02) cells via modulating Bcl-2 and Bax.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yue Tian Research Topics

Disease

10	Inflammation (Inflammations) 02/2022 - 05/2015
10	Cognitive Dysfunction 01/2022 - 09/2014
9	Neoplasms (Cancer) 01/2022 - 03/2012
5	Necrosis 04/2022 - 01/2017
4	Pain (Aches) 07/2021 - 09/2014
3	Hypoxia (Hypoxemia) 02/2022 - 01/2010
3	Periodontitis 01/2022 - 04/2020
3	Pulmonary Hypertension 12/2011 - 02/2008
2	Insulin Resistance 02/2022 - 09/2020
2	Glioma (Gliomas) 01/2022 - 06/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2015
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 01/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2021 - 01/2021
2	Wounds and Injuries (Trauma) 11/2020 - 01/2017
2	Hemorrhage 03/2019 - 08/2014
2	Postoperative Cognitive Complications 01/2018 - 01/2017
2	Neuroinflammatory Diseases 01/2018 - 05/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 09/2008
2	Rectal Neoplasms (Rectal Cancer) 08/2017 - 05/2015
2	Alzheimer Disease (Alzheimer's Disease) 08/2015 - 01/2012
1	Anxiety Disorders (Anxiety Disorder) 08/2022
1	Diabetes Complications 02/2022
1	Type 2 Diabetes Mellitus (MODY) 02/2022
1	Poisoning 01/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022
1	Pathologic Processes 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Liver Failure 01/2022
1	Olecranon Fracture 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Neurocognitive Disorders (Clerambault Syndrome) 12/2021

Drug/Important Bio-Agent (IBA)

6	Sevoflurane (Ultane)FDA LinkGeneric 12/2021 - 05/2015
5	Proteins (Proteins, Gene)FDA Link 09/2020 - 02/2002
4	Anesthetics (Anesthetic Agents)IBA 01/2021 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 08/2022 - 07/2021
3	BerberineIBA 02/2022 - 01/2022
3	Biological ProductsIBA 01/2022 - 06/2016
3	Peptides (Polypeptides)IBA 01/2019 - 01/2014
3	GoldIBA 01/2017 - 01/2012
3	Sulfur DioxideIBA 12/2011 - 09/2008
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2022 - 12/2017
2	GlycolipidsIBA 02/2022 - 09/2020
2	Caspase 3 (Caspase-3)IBA 02/2022 - 01/2017
2	Circular RNAIBA 01/2022 - 01/2022
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 11/2020
2	Ropivacaine (Naropin)FDA LinkGeneric 11/2020 - 06/2015
2	Midazolam (Versed)FDA LinkGeneric 01/2018 - 01/2015
2	CalciumIBA 12/2017 - 05/2017
2	CreatinineIBA 01/2016 - 02/2002
2	Amyloid beta-PeptidesIBA 08/2015 - 05/2015
2	Fentanyl (Sublimaze)FDA LinkGeneric 06/2015 - 09/2014
2	Small Interfering RNA (siRNA)IBA 12/2014 - 09/2014
2	Tissue Inhibitor of Metalloproteinase-1IBA 05/2002 - 02/2002
1	LigandsIBA 04/2022
1	GlucocorticoidsIBA 04/2022
1	Mitogen-Activated Protein KinasesIBA 02/2022
1	Aspartic Acid (Aspartate)FDA Link 02/2022
1	SphingosineIBA 02/2022
1	huanglian-jie-du decoctionIBA 02/2022
1	Peptide Hydrolases (Proteases)FDA Link 02/2022
1	Receptor for Advanced Glycation End ProductsIBA 02/2022
1	baicalinIBA 02/2022
1	Amino Acids FDA Link 02/2022
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 02/2022
1	gegenqinlianIBA 02/2022
1	coptisineIBA 02/2022
1	Xiexin decoctionIBA 02/2022
1	colla corii asiniIBA 02/2022
1	huanglianIBA 02/2022
1	Advanced Glycation End ProductsIBA 02/2022
1	Arachidonic Acid (Vitamin F)IBA 02/2022
1	purineIBA 02/2022
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2022
1	Valine (L-Valine)FDA Link 02/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Capsules (Microcapsules)IBA 01/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2022
1	EndotoxinsIBA 12/2021
1	schizandrin BIBA 12/2021
1	CurcuminIBA 12/2021
1	dibenzocyclooctadieneIBA 12/2021
1	LipopolysaccharidesIBA 12/2021

Therapy/Procedure

7	Therapeutics 01/2022 - 03/2012
3	Analgesia 11/2020 - 09/2014
2	Anesthesia 12/2021 - 05/2015
2	Radiotherapy 07/2021 - 03/2012
2	Drug Therapy (Chemotherapy) 07/2021 - 01/2018
2	Colectomy 11/2020 - 05/2020
2	Ileostomy 11/2020 - 08/2017
2	Hepatectomy 11/2019 - 01/2017
1	External Fixators 01/2022
1	Immunotherapy 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022